BWXT vs EW · P/E 46, rev $746.3M vs P/E 47, rev $1.39B
BWX Technologies Inc (BWXT) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
BWX Technologies Inc (BWXT) is a aerospace & defense company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported BWXT revenue for 2024-12-31 was $746.3M. Net income was $282.3M. Revenue was up 11.1% from 2024-09-30 to 2024-12-31. BWXT currently screens at market cap $13.06B and trailing P/E 45.5.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BWXT currently screens at market cap $13.06B and trailing P/E 45.5. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BWXT and EW stock pages for the full models.
Not investment advice.